Discontinuation report ONIVYDE
Report ID | 164803 |
Drug Identification Number | 02467135 |
Brand name | ONIVYDE |
Common or Proper name | Irinotecan |
Company Name | IPSEN BIOPHARMACEUTICALS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | IRINOTECAN |
Strength(s) | 4.3MG |
Dosage form(s) | SUSPENSION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 43mg/10mL |
ATC code | L01CE |
ATC description | |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | |
Remaining supply date | |
Discontinuation status | Reversed |
Discontinuation decision reversal | Yes |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 5050 SATELLITE DRIVE MISSISSAUGA, ONTARIO CANADA L4W 0G1 |
Company contact information | medinfoandsafetycanada@ipsen.com 1(855) 215-2288 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-07-18 | English | Compare |
v2 | 2022-07-18 | French | Compare |
v3 | 2022-08-23 | English | Compare |
v4 | 2022-08-23 | French | Compare |
v5 | 2022-12-22 | English | Compare |
v6 | 2022-12-22 | French | Compare |
v7 | 2023-01-25 | English | Compare |
Showing 1 to 7 of 7